Bifidobacterium
Also called bifidobacteria, Bifido.
By Dr Chad Okay3 min read
Bifidobacterium is a genus of bacteria that dominates the colon, especially in healthy infants and breastfed babies. They ferment dietary fibre into short-chain fatty acids, support immune function, and produce folate. Specific strains are well-studied probiotics for IBS, infant colic, and microbiome recovery after antibiotics.
What Bifidobacterium does
Bifidobacteria live mostly in the large intestine and ferment complex fibres that the small intestine can't digest. The end products are acetate, lactate, and indirectly butyrate (when other species cross-feed on bifido outputs). They train the immune system, lower colonic pH, and crowd out pathogens. They also produce folate, which is absorbed in the colon.
Strains with the strongest evidence
- Bifidobacterium infantis 35624 (sold as Align): improves bloating, gas and bowel habit in IBS in randomised trials.
- Bifidobacterium longum BB536: reduced influenza infection and fever in a trial in elderly adults; supports gut transit.
- Bifidobacterium breve M-16V: reduces eczema risk and severity in some infant trials.
- Bifidobacterium animalis subsp. lactis BB-12: improves bowel regularity, common in yoghurts.
- Bifidobacterium bifidum: foundational species, present in healthy breastfed infant guts.
Why they matter for infants
Healthy breastfed infants typically have a gut microbiome dominated by Bifidobacterium, often around 70% of bacteria on average. Human milk contains specific oligosaccharides (HMOs) that bifidobacteria are uniquely efficient at using, though some other gut bacteria can also consume them. This dominance trains the immune system, protects against pathogens, and influences long-term metabolic and allergy outcomes. Formula-fed and C-section infants have lower bifidobacteria, which is why some formulas now add HMOs and bifido strains directly.
Bifidobacterium vs Lactobacillus
- Niche: bifidobacteria mostly colon, lactobacilli mostly small intestine.
- Outputs: bifidobacteria produce acetate and lactate; lactobacilli mostly lactic acid.
- Oxygen: bifidobacteria are strict anaerobes (oxygen kills them); some lactobacilli tolerate oxygen.
- Both are common in probiotics; many products combine strains from both genera.
- Bifido strains are usually freeze-dried with stabilisers because they're so oxygen-sensitive.
How to encourage bifidobacteria
- Eat prebiotic fibres: inulin (onion, leek, garlic, asparagus, chicory), GOS (galacto-oligosaccharides, in legumes), and resistant starch (cooled cooked potato or rice).
- Eat polyphenols: berries, dark chocolate, green tea, red onion. Bifidobacteria thrive on these.
- Avoid frequent antibiotics. Bifidobacteria are particularly sensitive and can take months to recover.
- Breastfeed if possible. Human milk oligosaccharides selectively feed infant bifidobacteria.
- Targeted supplements (e.g. B. infantis 35624 for IBS, B. lactis BB-12 for regularity) when there's a specific reason.
Why it matters for the long run
Bifidobacteria decline across life, from dominance in infancy to a small fraction in older age, and diet quality is the one lever you keep. A fibre-and-polyphenol pattern sustained over years slows that decline, and every year the colony stays fed is a year of acetate and cross-fed butyrate quietly doing maintenance work on the gut lining.
Common questions
Bifidobacteria peak in infancy and decline through life. Lower fibre intake, more medications, slower gut transit, and immune ageing all contribute. Levels fall from being the dominant genus in infancy to a smaller fraction in adulthood (around 2 to 14%) and decline further in old age. Diet quality is the strongest factor you can control.
Sources
- 1Bifidobacteria and Their Role as Members of the Human Gut Microbiota, O'Callaghan & van Sinderen 2016Front Microbiol (PMID 27379055)
- 2Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with IBS (RCT), Whorwell et al 2006Am J Gastroenterol (PMID 16863564)
- 3Effects of Bifidobacterium longum BB536 on influenza infection and immunity in the elderly (RCT), Namba et al 2010Biosci Biotechnol Biochem (PMID 20460726)
- 4Exploring the Science behind Bifidobacterium breve M-16V in Infant Health (review of eczema/allergy trials), Wong et al 2019Nutrients (PMC6723912)
- 5Effect of Bifidobacterium animalis subsp. lactis BB-12 on defecation frequency (RCT), Eskesen et al 2015Br J Nutr (PMC4657032)
- 6Early development of infant gut microbiota in relation to breastfeeding and HMOs, 2023Front Nutr (PMC10034312)
- 7Gut Bifidobacteria Populations in Human Health and Aging, Arboleya et al 2016Front Microbiol (PMC4990546)
- 8Folate Production by Probiotic Bacteria, Rossi et al 2011Nutrients (PMC3257725)
- 9Probiotic Safety in Pregnancy: systematic review and meta-analysis of Lactobacillus, Bifidobacterium and Saccharomyces RCTs, Dugoua et al 2009J Obstet Gynaecol Can (PMID 19646321)
- 10ISAPP consensus statement on the definition and scope of synbiotics, Swanson et al 2020Nat Rev Gastroenterol Hepatol (PMC7581511)
- 11Genome of Bifidobacteria and Carbohydrate Metabolism (bifid shunt; acetate + lactate end products), Pokusaeva et alPMC4682508
- 12Bifidobacteria and Butyrate-Producing Colon Bacteria: cross-feeding to butyrate, Riviere et al 2016Front Microbiol (PMC4923077)
- 13Colonization Resistance in the Infant Gut: B. infantis reducing pH and preventing pathogen growth, 2020PMC7349288


